COCP - Cocrystal Pharma completes $4M equity offering priced ATM
2023-04-10 09:03:30 ET
- Cocrystal Pharma ( NASDAQ: COCP ) has announced the completion of a private placement of 2.03M shares of common stock at a price of $1.97/share for proceeds of $4M .
- Through this private placement Dr. Frost has increased his holdings and we welcome Mr. Hassan as a new shareholder,” said James Martin, co-CEO and CFO.
- Cocrystal is also preparing to file with the Australian regulatory agency to begin a first-in-human trial in its oral COVID-19 program with its novel, broad-spectrum protease inhibitor CDI-988.
- The Company also expects to select a lead oral candidate in its norovirus program by mid-2023.
- COCP +12.95% premarket to $2.18.
For further details see:
Cocrystal Pharma completes $4M equity offering priced ATM